Get started
Author

Ashley David Otter

Observed names: A Otter, A. Otter, A.D. Otter, Ash Otter, Ashley D Otter, Ashley D. Otter, Ashley Otter, Otter, Ashley
Observed institutions: St Bartholomew's Hospital, Barts Health NHS Trust, Public Health England, National Institute for Health and Care Research, European Society of Clinical Microbiology and Infectious Diseases, University of California Davis Medical Center, UC Davis Health, UK Health Security Agency, University College London, Cardiff University, University of California, Davis
ORCID: 0000-0002-8317-9194
Observed ORCID: 0000-0002-8317-9194
OpenAlex ID: A5068922045
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 810
PDF
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 687
PDF
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
2022 · Victoria Hall, Sarah Foulkes, et al. · New England Journal of Medicine · 675
PDF
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
2021 · Leo Swadling, Mariana O. Diniz, et al. · Nature · 395
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 390
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
2021 · Charlotte Manisty, Ashley D Otter, et al. · The Lancet · 363
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
2020 · Mark Ainsworth, Monique Andersson, et al. · The Lancet Infectious Diseases · 341
PDF
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
2021 · Catherine J. Reynolds, Corinna Pade, et al. · Science · 332
PDF
Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
2022 · Catherine J. Reynolds, Corinna Pade, et al. · Science · 325
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
2021 · Tim Peto, Dominic Affron, et al. · EClinicalMedicine · 235
PDF
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
2022 · Heather J. Whitaker, Ruby S.M. Tsang, et al. · Journal of Infection · 164
PDF
Extended interval BNT162b2 vaccination enhances peak antibody generation
2022 · Helen Parry, Rachel Bruton, et al. · npj Vaccines · 146
PDF
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
2023 · Eleanor Barnes, Carl S. Goodyear, et al. · Nature Medicine · 135
PDF
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
2022 · Catherine J. Reynolds, Joseph M. Gibbons, et al. · Science · 130
PDF
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
2021 · H. Parry, G. McIlroy, et al. · Blood Cancer Journal · 116
PDF
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
2021 · Roanne Keeton, Simone I. Richardson, et al. · Cell Host & Microbe · 109
PDF
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
2021 · Helen Parry, Rachel Bruton, et al. · Immunity & Ageing · 65
PDF
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
2021 · Rishi K Gupta, Joshua Rosenheim, et al. · The Lancet Microbe · 65
PDF
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
2021 · Charlotte Manisty, Thomas Alexander Treibel, et al. · EBioMedicine · 61
PDF
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
2023 · Ashley D. Otter, Scott Jones, et al. · Nature Communications · 58
PDF
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
2022 · Ana Atti, Ferdinando Insalata, et al. · Journal of Infection · 45
PDF
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response
2023 · Shamez N Ladhani, Alexander C Dowell, et al. · The Lancet Infectious Diseases · 43
PDF
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
2022 · Stuart Astbury, Catherine J. Reynolds, et al. · Immunology · 42
PDF
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
2021 · Javier Castillo-Olivares, David A. Wells, et al. · Frontiers in Immunology · 42
PDF
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis
2021 · Helen Parry, Rachel Bruton, et al. · The Lancet Healthy Longevity · 39
PDF
Works count: 88
Citation count: 7,103
H-index: 31
I10-index: 57
Year
Topic
Type